We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $18.6B
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
-3.37%
1 Year Est. Return
+15.81%
3 Year Est. Return
+66.02%
5 Year Est. Return
+80.97%
10 Year Est. Return
+273.41%
AUM
$18.6B
AUM Growth
+$313M
Cap. Flow
+$1.49B
Cap. Flow %
7.98%
Top 10 Hldgs %
34.36%
Holding
1,928
New
95
Increased
708
Reduced
377
Closed
128

Top Sells

Rank Stock Value
1
AKRE
Akre Focus ETF
AKRE
+$217M
2
ADP icon
Automatic Data Processing
ADP
+$153M
3
BKNG icon
Booking.com
BKNG
+$141M
4
MA icon
Mastercard
MA
+$140M
5
KLAC icon
KLA
KLAC
+$123M

Sector Composition

Rank Sector Weight
1 Technology 22.49%
2 Financials 14.15%
3 Industrials 9.47%
4 Healthcare 7.5%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCC icon
1376
Boise Cascade
BCC
$3.02B
$8.87K ﹤0.01%
117
+69
+144% +$5.53K
LMAT icon
1377
LeMaitre Vascular
LMAT
$1.86B
$8.84K ﹤0.01%
81
+79
+3,950% +$7.53K
MDB icon
1378
MongoDB
MDB
$32.1B
$8.81K ﹤0.01%
36
-1
-3% -$334
HAUZ icon
1379
Xtrackers International Real Estate ETF
HAUZ
$1.07B
$8.79K ﹤0.01%
389
PRKS icon
1380
United Parks & Resorts
PRKS
$2.12B
$8.79K ﹤0.01%
269
BSV icon
1381
Vanguard Short-Term Bond ETF
BSV
$44.6B
$8.78K ﹤0.01%
+112
New +$8.82K
HALO icon
1382
Halozyme
HALO
$12.2B
$8.72K ﹤0.01%
135
+8
+6% +$564
GIB icon
1383
CGI
GIB
$15.5B
$8.63K ﹤0.01%
118
WSFS icon
1384
WSFS Financial
WSFS
$4.15B
$8.57K ﹤0.01%
131
+18
+16% +$1.14K
PTGX icon
1385
Protagonist Therapeutics
PTGX
$9.44B
$8.54K ﹤0.01%
81
CPK icon
1386
Chesapeake Utilities
CPK
$3.21B
$8.47K ﹤0.01%
67
+29
+76% +$3.73K
MSA icon
1387
Mine Safety
MSA
$7.49B
$8.36K ﹤0.01%
51
-69
-58% -$12.6K
UNF icon
1388
Unifirst Corp
UNF
$5.25B
$8.3K ﹤0.01%
33
+22
+200% +$5.08K
BMNR
1389
BitMine Immersion Technologies
BMNR
$11.4B
$8.29K ﹤0.01%
+419
New +$9.87K
AU icon
1390
AngloGold Ashanti
AU
$48.7B
$8.28K ﹤0.01%
85
OSIS icon
1391
OSI Systems
OSIS
$3.89B
$8.23K ﹤0.01%
31
SMBS
1392
Schwab Mortgage-Backed Securities ETF
SMBS
$6.47B
$8.23K ﹤0.01%
322
SPB icon
1393
Spectrum Brands
SPB
$2.07B
$8.18K ﹤0.01%
111
FOLD
1394
DELISTED
Amicus Therapeutics
FOLD
$8.08K ﹤0.01%
559
+86
+18% +$1.23K
COLL icon
1395
Collegium Pharmaceutical
COLL
$956M
$8.04K ﹤0.01%
243
SPHR icon
1396
Sphere Entertainment
SPHR
$5.73B
$7.98K ﹤0.01%
68
-32
-32% -$3.35K
SPYM
1397
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$7.96K ﹤0.01%
104
MD icon
1398
Pediatrix Medical
MD
$2.2B
$7.96K ﹤0.01%
372
TMDX icon
1399
Transmedics
TMDX
$2.91B
$7.95K ﹤0.01%
80
+5
+7% +$652
TME icon
1400
Tencent Music
TME
$15.6B
$7.76K ﹤0.01%
836

Similar funds

Brown Brothers Harriman & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Brown Brothers Harriman & Co held 1,928 positions worth $18.6B, up 1.7% from $18.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brown Brothers Harriman & Co deployed $1.49B of net new capital in Q1 2026, opening 95 new positions and adding to 708 existing holdings. Its largest new stake was Golub Capital BDC: 942,550 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Akre Focus ETF, an estimated $217M trimmed.

  • Brown Brothers Harriman & Co's largest Q1 2026 buy was Golub Capital BDC: 942,550 shares worth $11.9M.
  • Brown Brothers Harriman & Co added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $417M increase.
  • Brown Brothers Harriman & Co's biggest Q1 2026 reduction was Akre Focus ETF, cutting an estimated $217M.
  • Brown Brothers Harriman & Co fully exited BlackRock MuniYield Fund in Q1 2026, selling an estimated $2.42M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 34% of its $18.6B portfolio in Q1 2026.
  • Brown Brothers Harriman & Co opened 95 new positions and closed 128 in Q1 2026.
  • Brown Brothers Harriman & Co's portfolio value rose 1.7% quarter-over-quarter to $18.6B.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.